Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Nuclear Area is a Prognostic Determinant in Advanced Colorectal Cancer

ABDELBASET BUHMEIDA, RAIJA RISTAMÄKI, HANAN LAMLUM, RIYAD BENDARDAF, SUVI HEIKKILÄ, YRJÖ COLLAN, KARI SYRJÄNEN and SEPPO PYRHÖNEN
Anticancer Research July 2005, 25 (4) 3083-3088;
ABDELBASET BUHMEIDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: abuhme{at}utu.fi
RAIJA RISTAMÄKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANAN LAMLUM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RIYAD BENDARDAF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUVI HEIKKILÄ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YRJÖ COLLAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KARI SYRJÄNEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SEPPO PYRHÖNEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 4 3083-3088
PMID 
16080569

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 21, 2005
  • Accepted May 17, 2005
  • Published online July 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ABDELBASET BUHMEIDA1,3,
  2. RAIJA RISTAMÄKI1,
  3. HANAN LAMLUM1,3,
  4. RIYAD BENDARDAF1,3,
  5. SUVI HEIKKILÄ1,
  6. YRJÖ COLLAN2,
  7. KARI SYRJÄNEN1 and
  8. SEPPO PYRHÖNEN1
  1. 1Department of Oncology and Radiotherapy, University of Turku, Turku, Finland
  2. 2Department of Pathology, Turku University Central Hospital, University of Turku, Turku, Finland
  3. 3Department of MediCity Research Laboratory, University of Turku, Turku, Finland
  1. Correspondence to: Abdelbaset Buhmeida, MD, Dr. Med. Sci., Department of Oncology and Radiotherapy, Turku University Central Hospital, P.O. Box 52 (Savitehtaankatu 1), FIN-20521 Turku, Finland. Tel: +358 2 3337016, Fax: +358 2 333 7000, e-mail: abuhme{at}utu.fi

Statistics from Altmetric.com

Cited By...

  • 6 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 4
1 Jul 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nuclear Area is a Prognostic Determinant in Advanced Colorectal Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nuclear Area is a Prognostic Determinant in Advanced Colorectal Cancer
ABDELBASET BUHMEIDA, RAIJA RISTAMÄKI, HANAN LAMLUM, RIYAD BENDARDAF, SUVI HEIKKILÄ, YRJÖ COLLAN, KARI SYRJÄNEN, SEPPO PYRHÖNEN
Anticancer Research Jul 2005, 25 (4) 3083-3088;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nuclear Area is a Prognostic Determinant in Advanced Colorectal Cancer
ABDELBASET BUHMEIDA, RAIJA RISTAMÄKI, HANAN LAMLUM, RIYAD BENDARDAF, SUVI HEIKKILÄ, YRJÖ COLLAN, KARI SYRJÄNEN, SEPPO PYRHÖNEN
Anticancer Research Jul 2005, 25 (4) 3083-3088;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Clinical Outcomes and Prognostic Factors in Patients With Pelvic Sarcomas
  • The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib Therapy
  • Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire